Healthcare (Medical Licensing)

This bill, titled the Ban Abortion by Mail Act, aims to restrict how abortion medications like mifepristone are prescribed by requiring an in-person visit between the patient and the doctor. It directly affects health care providers who are currently certified by the FDA to dispense these drugs, threatening their certification status if they prescribe them without a physical examination or to patients living in states where the provider lacks a medical license. The legislation mandates that the FDA report annually to Congress on any providers who lose this certification due to violations or unsafe prescribing practices. By enforcing these specific conditions, the bill seeks to ensure that all prescriptions for abortion drugs are administered under strict supervision and within the legal boundaries of the patient's state.